Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial

Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial

Submitted by admin on June 10, 2019 - 7:34pm
Source: 
Biopharma Dive
News Tags: 
Sanofi
diabetes
ADA
Soliqua
clinical trials
Headline: 
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
snippet: 

A Phase III trial compared Sanofi’s Soliqua/Suliqua to other GLP-1 receptor agonists (GLP-1 RA), with Soliqua showing a superior decrease of average blood sugar level (HbA1c) after 26 weeks.

Do Not Allow Advertisers to Use My Personal information